HOME CONSORTIUM LIMITED (HMC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HMC - HOME CONSORTIUM LIMITED

Year End: June
GICS Industry Group : Real Estate
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.99

12 Aug
2022

-0.240

OPEN

$5.15

-4.59%

HIGH

$5.15

0

LOW

$4.99

TARGET
$6.338 27.0% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AMP . ASX . BLA . PDL . CGF . GBST . HGG . IFL . IRE . MFG . PPS . PPT . PTM . CVW . JHG . CL1 . ENN . KAM . KSL . BVS . PNI . MOE . NWL . LNK . GBT . HUB . NGI . GDG . AEF . PAC . MQG . MAF . MAI . GDC . GQG . TDI . RZI . QAL . AVC .
FNARENA'S MARKET CONSENSUS FORECASTS
HMC: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx - 19.9 29.1 xxx
DPS (cps) xxx 79.5 12.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx 100.0% - 84.9% xxx
PE Ratio xxx N/A 17.6 xxx
Dividend Yield xxx N/A 2.3% xxx
Div Pay Ratio(%) xxx N/A 41.3% xxx

Dividend yield today if purchased 3 years ago: 1,656.25%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

15.53

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 01/03 - ex-div 6c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 20202021
EPS Basic xxx-19.9
DPS All xxx79.5
Sales/Revenue xxx69.8 M
Book Value Per Share xxx243.7
Net Operating Cash Flow xxx25.8 M
Net Profit Margin xxx-143.08 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20202021
Return on Capital Employed xxx-13.91 %
Return on Invested Capital xxx-9.12 %
Return on Assets xxx-8.84 %
Return on Equity xxx-13.91 %
Return on Total Capital xxx3.20 %
Free Cash Flow ex dividends xxx-10.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxxxxxxx xx xxxxxxxx xxxx xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

02/06/2022

3

Neutral

$6.16

23.45%

Credit Suisse has adjusted estimates for Australian real estate investment trusts (A-REITs) to account for rising costs and interest rates, noting while it cannot be certain where rates will settle it has assumed a 1.5% increase to costs of debt exposure in FY23. 

The broker highlighted those companies with lower gearing and higher hedging were better insulated from the impacts of rising rates. With HomeCo currently debt free, the broker notes rising rates are unlikely to have any material impact. 

The Neutral rating is retained and the target price decreases to $6.16 from $6.74, reflecting a market reluctance to pay a high multiple rather than changes to earnings.

FORECAST
Credit Suisse forecasts a full year FY22 dividend of 12.00 cents and EPS of 29.00 cents.
Credit Suisse forecasts a full year FY23 dividend of 12.00 cents and EPS of 30.00 cents.

UBS

xx/xx/xxxx

3

xxxxxxx xx xxxxxxx xxxx xxxx

$xx.xx

(xx/xx/xxxx)

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

HMC STOCK CHART